Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives-Reference-Cited by-同舟云学术

Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives

Published:2009-06-24 Issue:7 Volume:18 Page:973-983
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Samuel David P¹,Wen Patrick Y²,Kieran Mark W¹

Affiliation:

1. Harvard Medical School, Pediatric Medical Neuro-Oncology, Dana-Farber Cancer Institute and Children's Hospital of Boston, 44 Binney Street, Room SW331, Boston, MA 02115, USA ; ;

2. Harvard Medical School, Dana-Farber/Brigham and Women's Cancer Center, Room SW430D, 44 Binney Street, Boston, MA 02115, USA

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543780903025752

Reference119 articles.

1. Angiogenesis

2. New developments in targeted molecular therapies for glioblastoma

3. Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in children with brain tumours;Advances in Clinical and Experimental Medicine;2017-06-26

2. Anti-angiogenic therapy in pediatric brain tumors: An effective strategy?;Critical Reviews in Oncology/Hematology;2014-03

3. Clinical Activity of Metronomic Chemotherapy in Central Nervous System Cancers;Metronomic Chemotherapy;2014

4. Metabolic Management of Cancer;Cancer as a Metabolic Disease;2012-05-29

5. Cancer and the Nervous System;Neurology in Clinical Practice;2012